Literature DB >> 12820156

Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation.

Donald E Mager1, Nasir Moledina, William J Jusko.   

Abstract

The in vitro immunosuppressive potency of several therapeutic corticosteroids was investigated using a whole-blood lymphocyte proliferation assay. The selected steroids included beclomethasone dipropionate (BDP), betamethasone (BET), budesonide (BUD), dexamethasone (DEX), flunisolide (FLU), fluticasone propionate (FTP), hydrocortisone (HC), methylprednisolone (MPL), prednisolone (PNL), and triamcinolone acetonide (TAA). The ability of phytohemagglutinin to stimulate lymphocytes in whole blood samples obtained from six drug-free male volunteers was tested against drug concentrations ranging from approximately 0.2 to 2000 nM. Data analysis was conducted employing an inhibitory Hill function and nonlinear regression analysis in ADAPT II. The order of drug concentrations producing 50% inhibition (IC(50)) from highest to lowest was HC > PNL > MPL > BDP > BET > DEX > TAA > FLU > BUD > FTP. These IC(50) values are an inverse measure of drug potency, with FTP representing the most potent corticosteroid examined. A linear correlation was found between the log-transformed 1/IC(50) values and the log of the relative receptor affinity (RRA) values obtained from the literature (r(2) = 0.95). These results extend previous studies to include relatively new corticosteroids and further support the use of RRA values as an indirect measure of relative in vitro immunosuppressive potency. Copyright 2003 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820156     DOI: 10.1002/jps.10402

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1.

Authors:  Lora Hamuro; Giridhar S Tirucherai; Sean M Crawford; Akbar Nayeem; Renuka C Pillutla; Binodh S DeSilva; Tarek A Leil; Craig J Thalhauser
Journal:  AAPS J       Date:  2019-07-24       Impact factor: 4.009

2.  Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.

Authors:  Chris Stockmann; Bernhard Fassl; Roger Gaedigk; Flory Nkoy; Derek A Uchida; Steven Monson; Christopher A Reilly; J Steven Leeder; Garold S Yost; Robert M Ward
Journal:  J Pediatr       Date:  2013-01-03       Impact factor: 4.406

Review 3.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

4.  Intralesional Injection of Triamcinolone Acetonide for Subcutaneous Lipoma causing Musculoskeletal and Neurologic Symptoms.

Authors:  William A Hayward; Wilmer L Sibbitt; Randy R Sibbitt; Maheswari Muruganandam; Noelle A Rolle; Monthida Fangtham; N Suzanne Emil; Scarlett K Kettwich
Journal:  J Clin Aesthet Dermatol       Date:  2018-05-01

Review 5.  Chronopharmacology of glucocorticoids.

Authors:  Megerle L Scherholz; Naomi Schlesinger; Ioannis P Androulakis
Journal:  Adv Drug Deliv Rev       Date:  2019-02-21       Impact factor: 15.470

Review 6.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen.

Authors:  Xiaonan Li; Debra C DuBois; Dawei Song; Richard R Almon; William J Jusko; Xijing Chen
Journal:  Drug Metab Dispos       Date:  2017-04-17       Impact factor: 3.922

8.  Effects of representative glucocorticoids on TNFα- and CD40L-induced NF-κB activation in sensor cells.

Authors:  Sirlene R Cechin; Peter Buchwald
Journal:  Steroids       Date:  2014-04-18       Impact factor: 2.668

9.  Mammalian Cells Engineered To Produce New Steroids.

Authors:  Emma S Spady; Thomas P Wyche; Nathanael J Rollins; Jon Clardy; Jeffrey C Way; Pamela A Silver
Journal:  Chembiochem       Date:  2018-07-26       Impact factor: 3.164

10.  Comparing oxytocin and cortisol regulation in a double-blind, placebo-controlled, hydrocortisone challenge pilot study in children with autism and typical development.

Authors:  Blythe A Corbett; Karen L Bales; Deanna Swain; Kevin Sanders; Tamara A R Weinstein; Louis J Muglia
Journal:  J Neurodev Disord       Date:  2016-08-18       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.